Sally Swift
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
Papers in
- Genetics 6
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 4
- BRCA gene mutations in cancer 2
- Co-authors
- Alan AshworthChristopher J. LordNicholas C. TurnerNeil BrockdorffGraham F. KayAndrew TuttDominic P. NorrisPenny Cooper
- Journals
- Nucleic Acids Research (2 papers)Genomics (2 papers)The EMBO Journal (1 paper)Nature Genetics (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomAustraliaNetherlands
In The Last Decade
Sally Swift
14 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.3k
- Cancer Research 698
- Genetics 1.1k
- Molecular Biology 2.6k
- Reproductive Medicine 194
Countries citing papers authored by Sally Swift
This map shows the geographic impact of Sally Swift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Swift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Swift more than expected).
Fields of papers citing papers by Sally Swift
This network shows the impact of papers produced by Sally Swift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Swift. The network helps show where Sally Swift may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sally Swift, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 23 | |
| 2 | 2009 | 143 | |
| 3 | 2008 | 135 | |
| 4 | 2008 | 222 | |
| 5 | 2008 | 254 | |
| 6 | Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition Hit paper breakdown → | 2006 | 977 |
| 7 | 1999 | 26 | |
| 8 | 1998 | 3 | |
| 9 | 1997 | 345 | |
| 10 | 1995 | 6 | |
| 11 | The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus Hit paper breakdown → | 1992 | 824 |
| 12 | 1992 | 128 | |
| 13 | 1991 | 102 | |
| 14 | 1989 | 43 |
About Sally Swift
Sally Swift is a scholar working on Genetics, Gender Studies, Virology, Cancer Research and Molecular Biology, having authored 14 papers that have together received 3.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), CRISPR and Genetic Engineering (5 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers), interferon and immune responses (3 papers), PARP inhibition in cancer therapy (3 papers), BRCA gene mutations in cancer (2 papers), Ubiquitin and proteasome pathways (2 papers) and Sexual Differentiation and Disorders (2 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (698 citations), Genetics (1.1k citations), Molecular Biology (2.6k citations) and Reproductive Medicine (194 citations). Sally Swift has collaborated with scholars based in United Kingdom, Australia and Netherlands. Frequent co-authors include Alan Ashworth, Christopher J. Lord, Nicholas C. Turner, Neil Brockdorff, Graham F. Kay, Andrew Tutt, Dominic P. Norris, Penny Cooper, Veronica McCabe and Sohaila Rastan. Their work appears in journals such as Nucleic Acids Research, Genomics, The EMBO Journal, Nature Genetics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.